PL370536A1 - Kompozycje do leczenia przeziębienia - Google Patents

Kompozycje do leczenia przeziębienia

Info

Publication number: PL370536A1
Authority: PL; Poland
Prior art keywords: compositions; common cold; treatment; salt; combination
Prior art date: 2001-09-18

Application number

PL02370536A

Other languages

English (en)

Other versions

PL208686B1 (pl

Inventor

Hanne Anette Moesgaard

Karin Lowenstein Christensen

Original Assignee

Nycomed Danmark Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-18

Filing date

2002-09-18

Publication date

2005-05-30

2002-09-18 Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps

2005-05-30 Publication of PL370536A1 publication Critical patent/PL370536A1/pl

2011-05-31 Publication of PL208686B1 publication Critical patent/PL208686B1/pl

Links

239000000203 mixture Substances 0.000 title abstract 4
201000009240 nasopharyngitis Diseases 0.000 title abstract 2
150000003839 salts Chemical class 0.000 abstract 2
YGWFCQYETHJKNX-UHFFFAOYSA-N 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound [Cl-].CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCC[NH2+]1 YGWFCQYETHJKNX-UHFFFAOYSA-N 0.000 abstract 1
208000036071 Rhinorrhea Diseases 0.000 abstract 1
206010039101 Rhinorrhoea Diseases 0.000 abstract 1
239000000812 cholinergic antagonist Substances 0.000 abstract 1
OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 abstract 1
229960001888 ipratropium Drugs 0.000 abstract 1
210000002850 nasal mucosa Anatomy 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
239000005526 vasoconstrictor agent Substances 0.000 abstract 1
229960001095 xylometazoline hydrochloride Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Polyurethanes Or Polyureas (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Cosmetics (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

PL370536A 2001-09-18 2002-09-18 Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli PL208686B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200101356		2001-09-18

Publications (2)

Publication Number	Publication Date
PL370536A1 true PL370536A1 (pl)	2005-05-30
PL208686B1 PL208686B1 (pl)	2011-05-31

Family

ID=8160714

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL370536A PL208686B1 (pl)	2001-09-18	2002-09-18	Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli

Country Status (20)

Country	Link
US (2)	US7652030B2 (pl)
EP (2)	EP1661570A3 (pl)
JP (1)	JP4500045B2 (pl)
KR (1)	KR100810872B1 (pl)
CN (1)	CN1290502C (pl)
AT (1)	ATE318601T1 (pl)
BR (1)	BRPI0212586B8 (pl)
CA (1)	CA2460140C (pl)
DE (1)	DE60209511T2 (pl)
DK (1)	DK1446119T3 (pl)
EA (1)	EA008165B1 (pl)
ES (1)	ES2259098T3 (pl)
HU (1)	HU226527B1 (pl)
MX (1)	MXPA04002500A (pl)
NO (1)	NO334441B1 (pl)
NZ (1)	NZ531792A (pl)
PL (1)	PL208686B1 (pl)
PT (1)	PT1446119E (pl)
SI (1)	SI1446119T1 (pl)
WO (1)	WO2003024433A2 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
NZ531792A (en) *	2001-09-18	2006-02-24	Nycomed Danmark Aps	Compositions for treatment of common cold
TWI359675B (en) *	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
RU2006132043A (ru) *	2004-02-06	2008-03-20	МЕДА Фарма ГмбХ унд Ко.КГ (DE)	Комбинация и фармацевтический препарат для лечения ринита
WO2005084330A2 (en) *	2004-03-02	2005-09-15	Synergia Pharma, Inc.	Compositions and methods for treating nasal congestion
DE102004049008A1 (de) *	2004-10-05	2006-04-06	Merck Patent Gmbh	Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
US8481565B2 (en) *	2004-12-27	2013-07-09	Eisai R&D Management Co., Ltd.	Method for stabilizing anti-dementia drug
DE102006023770A1 (de) *	2006-05-20	2007-11-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en)	2008-01-02	2009-07-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) *	2008-04-25	2009-10-29	Kenneth Gould	Method to use oxymetazoline to interrupt the development of the common cold syndrome
EP2414560B1 (de)	2009-03-31	2013-10-23	Boehringer Ingelheim International GmbH	Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de)	2009-05-18	2020-12-23	Boehringer Ingelheim International GmbH	Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es)	2009-11-25	2012-06-14	Boehringer Ingelheim Int	Nebulizador.
JP5658268B2 (ja)	2009-11-25	2015-01-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ネブライザ
US10016568B2 (en)	2009-11-25	2018-07-10	Boehringer Ingelheim International Gmbh	Nebulizer
JP5874724B2 (ja)	2010-06-24	2016-03-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ネブライザ
WO2012130757A1 (de)	2011-04-01	2012-10-04	Boehringer Ingelheim International Gmbh	Medizinisches gerät mit behälter
US9827384B2 (en)	2011-05-23	2017-11-28	Boehringer Ingelheim International Gmbh	Nebulizer
WO2013152894A1 (de)	2012-04-13	2013-10-17	Boehringer Ingelheim International Gmbh	Zerstäuber mit kodiermitteln
WO2014158118A1 (en) *	2013-03-29	2014-10-02	Santa Farma İlaç Sanayi̇ A.Ş.	Suspension composition containing ipratropium and oxymetazoline
WO2014158119A1 (en) *	2013-03-29	2014-10-02	Santa Farma İlaç Sanayi̇ A.Ş	Aqueous solution composition containing ipratropium and oxymetazoline
EP2835146B1 (en)	2013-08-09	2020-09-30	Boehringer Ingelheim International GmbH	Nebulizer
WO2015018904A1 (en)	2013-08-09	2015-02-12	Boehringer Ingelheim International Gmbh	Nebulizer
WO2015054359A1 (en) *	2013-10-08	2015-04-16	Ebadi Mark A	Methods and compositions for symptomatic reflief of the common cold
BR122022010094B1 (pt)	2014-05-07	2023-10-03	Boehringer Ingelheim International Gmbh	Dispositivo indicador e recipiente
WO2015169430A1 (en)	2014-05-07	2015-11-12	Boehringer Ingelheim International Gmbh	Nebulizer
MX383195B (es)	2014-05-07	2025-03-13	Boehringer Ingelheim Int	Recipiente, nebulizador y uso.
EP3236933B1 (en)	2014-12-24	2018-11-14	JADRAN - GALENSKI LABORATORIJ d.d.	A nasal composition containing sea water as stability-improving excipient
MX383771B (es) *	2015-12-02	2025-03-14	Pablo Cortes Borrego	Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) *	2020-07-31	2022-02-03	Eye Therapies Llc	Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69229880T2 (de) *	1991-11-19	2000-05-04	The University Of Virginia Patent Foundation, Charlottesville	Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
IL101056A (en) *	1992-02-24	1997-03-18	Res & Dev Co Ltd	Composition for nasal treatment
GB9218834D0 (en)	1992-09-05	1992-10-21	Procter & Gamble	Nasal spray products
EP0673240B1 (en)	1992-12-09	1999-03-24	Boehringer Ingelheim Pharmaceuticals Inc.	Stabilized medicinal aerosol solution formulations
EP0780127A1 (en)	1995-12-19	1997-06-25	The Procter & Gamble Company	A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
CA2281789A1 (en) *	1997-04-30	1998-11-05	Warner-Lambert Company	Topical nasal antiinflammatory compositions
DE69901936T2 (de) *	1998-01-30	2002-11-28	Novartis Consumer Health S.A., Nyon	Nasale lösungen
KR100600423B1 (ko)	1998-06-18	2006-07-13	베링거 인겔하임 파마슈티칼즈, 인코포레이티드	2개 이상의 활성 물질을 포함하는 연무질 약제학적 제형
WO2000078297A2 (de) *	1999-06-22	2000-12-28	Boehringer Ingelheim International Gmbh	Stabile xylometazolin- und oxymetazolinlösung
NZ531792A (en) *	2001-09-18	2006-02-24	Nycomed Danmark Aps	Compositions for treatment of common cold

2002
- 2002-09-18 NZ NZ531792A patent/NZ531792A/en not_active IP Right Cessation
- 2002-09-18 WO PCT/IB2002/003828 patent/WO2003024433A2/en not_active Ceased
- 2002-09-18 EP EP06075452A patent/EP1661570A3/en not_active Withdrawn
- 2002-09-18 CN CNB028182871A patent/CN1290502C/zh not_active Expired - Lifetime
- 2002-09-18 CA CA002460140A patent/CA2460140C/en not_active Expired - Lifetime
- 2002-09-18 EA EA200400444A patent/EA008165B1/ru unknown
- 2002-09-18 HU HU0402075A patent/HU226527B1/hu unknown
- 2002-09-18 EP EP02765268A patent/EP1446119B1/en not_active Expired - Lifetime
- 2002-09-18 BR BRPI0212586A patent/BRPI0212586B8/pt not_active IP Right Cessation
- 2002-09-18 PL PL370536A patent/PL208686B1/pl unknown
- 2002-09-18 DK DK02765268T patent/DK1446119T3/da active
- 2002-09-18 PT PT02765268T patent/PT1446119E/pt unknown
- 2002-09-18 MX MXPA04002500A patent/MXPA04002500A/es active IP Right Grant
- 2002-09-18 SI SI200230311T patent/SI1446119T1/sl unknown
- 2002-09-18 ES ES02765268T patent/ES2259098T3/es not_active Expired - Lifetime
- 2002-09-18 JP JP2003528530A patent/JP4500045B2/ja not_active Expired - Lifetime
- 2002-09-18 DE DE60209511T patent/DE60209511T2/de not_active Expired - Lifetime
- 2002-09-18 AT AT02765268T patent/ATE318601T1/de active
- 2002-09-18 KR KR1020047003882A patent/KR100810872B1/ko not_active Expired - Lifetime
- 2002-09-18 US US10/489,655 patent/US7652030B2/en not_active Expired - Lifetime
2004
- 2004-03-12 NO NO20041070A patent/NO334441B1/no not_active IP Right Cessation
2009
- 2009-12-11 US US12/654,145 patent/US8450339B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HUP0402075A2 (hu)	2005-02-28
JP4500045B2 (ja)	2010-07-14
BRPI0212586B8 (pt)	2021-05-25
KR100810872B1 (ko)	2008-03-06
EP1446119A2 (en)	2004-08-18
CN1555263A (zh)	2004-12-15
US7652030B2 (en)	2010-01-26
WO2003024433A2 (en)	2003-03-27
EP1661570A3 (en)	2012-10-24
DE60209511D1 (de)	2006-04-27
WO2003024433A3 (en)	2004-06-10
BR0212586B1 (pt)	2013-11-19
MXPA04002500A (es)	2004-11-22
EA200400444A1 (ru)	2005-02-24
ATE318601T1 (de)	2006-03-15
HK1067984A1 (en)	2005-04-22
BR0212586A (pt)	2004-10-13
CA2460140C (en)	2009-09-01
NZ531792A (en)	2006-02-24
CA2460140A1 (en)	2003-03-27
CN1290502C (zh)	2006-12-20
US20040248924A1 (en)	2004-12-09
ES2259098T3 (es)	2006-09-16
NO20041070L (no)	2004-05-18
EP1661570A2 (en)	2006-05-31
EP1446119B1 (en)	2006-03-01
PL208686B1 (pl)	2011-05-31
HU226527B1 (hu)	2009-03-30
HUP0402075A3 (en)	2008-04-28
SI1446119T1 (sl)	2006-08-31
DE60209511T2 (de)	2006-10-05
US8450339B2 (en)	2013-05-28
NO334441B1 (no)	2014-03-03
DK1446119T3 (da)	2006-07-10
US20100093783A1 (en)	2010-04-15
PT1446119E (pt)	2006-07-31
JP2005505569A (ja)	2005-02-24
KR20040049849A (ko)	2004-06-12
EA008165B1 (ru)	2007-04-27

Legal Events

Date	Code	Title	Description
2012-01-31	RECP	Rectifications of patent specification

Publication	Publication Date	Title
SI1446119T1 (sl)	2006-08-31	Sestavki, ki obsegajo ipratorij in ksilometazolin, za zdravljenje obicajnega prehlada
SI1458360T1 (sl)	2011-08-31	Pulmonalno dajanje aminoglikozidov
WO2002070510A3 (de)	2003-01-30	Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
JO2311B1 (en)	2005-09-12	Alkyl inhibitors Ariel phosphodiesterase-4
BR9812361A (pt)	2000-09-19	Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
WO2003009838A1 (en)	2003-02-06	Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
MXPA04002825A (es)	2004-07-02	Derivados de quinolina como antagonistas de neuropeptido y.
WO2002085909A8 (en)	2004-04-29	9-deazaguanine derivatives as inhibitors of gsk-3
NO2007010I2 (no)	2009-12-14	Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
IL161154A0 (en)	2004-08-31	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200504078A (en)	2005-02-01	Therapeutically active compounds and their use
NO307495B1 (no)	2000-04-17	Anvendelse av riluzol ved fremstilling av medikamenter for behandling av Parkinsons sykdom og Parkinsonske syndromer
MXPA03010761A (es)	2004-03-02	Combinaciones farmaceuticas.
NO20045677L (no)	2005-02-28	Inhibitorer av JAK- og CDK2-proteinkinaser
SI1546127T1 (sl)	2008-08-31	Novi pirimidinamidni derivati in njihova uporaba
DE60128912D1 (en)	2007-07-26	Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
WO2002088100A3 (de)	2003-05-30	Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2003087049A3 (de)	2004-02-05	Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
WO2002072584A3 (en)	2003-01-03	Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders
WO2004082706A3 (en)	2005-01-13	Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders
SG152257A1 (en)	2009-05-29	Topical preparation containing ambroxol
WO2002072571A3 (en)	2003-10-30	Pyridinyl pyrazoles useful for the treatment of copd
BR0212329A (pt)	2004-09-21	Métodos para tratar doença pulmonar
WO2002065989A3 (en)	2002-12-12	Aminoglycoside treatment for lysosomal storage diseases
WO2005039483A3 (en)	2005-09-29	Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity